I agree, we don't get any info on NASH 700 and all of a sudden silence. We know the results are good or break even so this indicates to me negotiations started for a partner or buy out.

At first I thought Omicron, but they would have just announced it and postponed. There are a whole bunch of other possibilities that are good. Something on Long Haulers or Brazil or cancer or NASH or HIV, or major development on Amarex.